Viatris Inc financial data

Symbol
VTRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1000 Mylan Boulevard, Canonsburg, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Upjohn Inc (to 11/10/2020)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 158 % -0.4%
Quick Ratio 54.6 % +2.96%
Operating Margin 0.07 % -98.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.19B shares +0.25%
Entity Public Float 12.7B USD +6.07%
Common Stock, Value, Issued 12.3M USD +0.82%
Weighted Average Number of Shares Outstanding, Basic 1.19B shares -0.5%
Weighted Average Number of Shares Outstanding, Diluted 1.2B shares -0.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 14.7B USD -4.46%
Revenue from Contract with Customer, Excluding Assessed Tax 14.7B USD -4.52%
Research and Development Expense 198M USD -6.06%
Operating Income (Loss) 10.1M USD -98.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -623M USD -407%
Income Tax Expense (Benefit) 11M USD -92.6%
Earnings Per Share, Basic -0.53 USD/shares -1160%
Earnings Per Share, Diluted -0.53 USD/shares -1160%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 735M USD -25.9%
Accounts Receivable, after Allowance for Credit Loss, Current 3.22B USD -12.9%
Inventory, Net 3.85B USD +11.1%
Other Assets, Current 387M USD +42.9%
Assets, Current 9.52B USD -26.6%
Deferred Income Tax Assets, Net 753M USD +8.67%
Property, Plant and Equipment, Net 2.67B USD -3.39%
Operating Lease, Right-of-Use Asset 253M USD +3.05%
Intangible Assets, Net (Excluding Goodwill) 17.1B USD -11%
Goodwill 9.13B USD -7.44%
Other Assets, Noncurrent 2.36B USD +6.71%
Assets 41.5B USD -13%
Employee-related Liabilities, Current 729M USD -13.6%
Liabilities, Current 5.78B USD -25.7%
Deferred Income Tax Liabilities, Net 1.11B USD -36.2%
Operating Lease, Liability, Noncurrent 179M USD +8.4%
Other Liabilities, Noncurrent 1.94B USD +27.8%
Liabilities 22.9B USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.21B USD -16.9%
Retained Earnings (Accumulated Deficit) 3.42B USD -26.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 18.6B USD -8.95%
Liabilities and Equity 41.5B USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 615M USD -36.7%
Net Cash Provided by (Used in) Financing Activities -426M USD +56.3%
Net Cash Provided by (Used in) Investing Activities -154M USD +79.4%
Common Stock, Shares Authorized 3B shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 22.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 736M USD -25.9%
Deferred Tax Assets, Valuation Allowance 1.23B USD +193%
Deferred Tax Assets, Gross 2.89B USD +33.8%
Operating Lease, Liability 266M USD +7.25%
Payments to Acquire Property, Plant, and Equipment 49.8M USD +4.18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 384M USD +198%
Lessee, Operating Lease, Liability, to be Paid 298M USD +9.94%
Property, Plant and Equipment, Gross 4.87B USD +2.08%
Operating Lease, Liability, Current 87.1M USD +4.94%
Lessee, Operating Lease, Liability, to be Paid, Year Two 71.1M USD +13.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 78.2M USD -1.39%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -51.9M USD -94.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 31.2M USD +39.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 46.4M USD +11.8%
Deferred Tax Assets, Operating Loss Carryforwards 735M USD
Unrecognized Tax Benefits 256M USD -6.27%
Lessee, Operating Lease, Liability, to be Paid, Year Four 25.6M USD -15.8%
Additional Paid in Capital 18.9B USD +0.57%
Amortization of Intangible Assets 2.35B USD +1.49%
Depreciation, Depletion and Amortization 691M USD -5.34%
Deferred Tax Assets, Net of Valuation Allowance 1.65B USD -4.8%
Interest Expense 550M USD -4.03%